Heart drug developer Kardigan Inc. priced its IPO shares at $16 — bringing in $400 million — ahead of open-market sales of ...
The 14-person firm leased 2,700 square feet on East Market Street. Managing partner Bill Lentini says the move supports plans ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results